46634.1 IP-LS

Résumé

Antibody-based topical treatment for corneal transplant rejection

Textes supplémentaires

Abstract

There is a critical need for novel therapies that prevent corneal transplant rejection. The goal of the project is to optimise an antibody-based therapy for use as a topical treatment and validate proof of concept in corneal transplant rejection and dry eye disease.

Participants

Cornelia Halin Winter

Kontaktperson

cornelia.halin@pharma.ethz.ch

ETH Zürich Cornelia Halin Winter Vladimir-Prelog-Weg 1-5/10 8093 Zürich ZH CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-12-31
Date de fin: 2022-01-31
Coûts totaux approuvés: CHF 277070.64
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T410 Pharmaceuticals and related technologies 100.0%